NEOGENOMICS INC — Director's Dealing 2021

Dec 31, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2021-12-30

Reporting Person: Mallon Mark (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-30	Common Stock	A	152858	—	Acquired	225594	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$49.34	2028-04-19	Common Stock (151016.0)	151016	Direct

Footnotes

F1: On December 30, 2021, Mr. Mallon was granted 152,858 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.

F2: On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date.